Pharmacokinetics of intravitreally injected bevacizumab in vitrectomized eyes. - Wikidata - wikimedia - TriplyDB

Pharmacokinetics of intravitreally injected bevacizumab in vitrectomized eyes.

Pharmacokinetics of intravitreally injected bevacizumab in vitrectomized eyes.

http://www.wikidata.org/entity/Q37133086

about

Efficacy of 0.2 μg/day fluocinolone acetonide implant (ILUVIEN) in eyes with diabetic macular edema and prior vitrectomy Efficacy and safety of different doses of a slow-release corticosteroid implant for macular edema: meta-analysis of randomized controlled trials Intraocular pharmacokinetics of intravitreal vascular endothelial growth factor-Trap in a rabbit model.Pharmacokinetics, pharmacodynamics and pre-clinical characteristics of ophthalmic drugs that bind VEGF.Sustained-release corticosteroid options.Short-term Efficacy of Intravitreal Dexamethasone Implant in Vitrectomized Eyes with Recalcitrant Diabetic Macular Edema and Prior Anti-VEGF Therapy.Pharmacokinetics of intravitreal anti-VEGF drugs in vitrectomized versus non-vitrectomized eyes.Estimation of Intra-vitreal Half-Lifes in the Rabbit Eye with Semi-mechanistic Equations.Ultra-low dose of intravitreal bevacizumab in retinopathy of prematurity.Comparison of efficacy of intravitreal ranibizumab between non-vitrectomized and vitrectomized eyes with diabetic macular edema.

P2860

Q33705718-73D6EFBF-6264-4287-A4AA-3441228D798E Q35594036-8C91254A-6FA1-4E30-B2B0-38D6F49BD265 Q36752250-06A5D176-5CEA-4BB2-A057-BF5D380FB7DE Q38183850-7361AEBE-DF5F-4074-A68A-A712908D03A4 Q38241548-FDDFBF3C-778E-4B33-8105-CC4D87FCC744 Q42126619-123B040F-53DD-4F15-BE10-ED4DDC3EA40D Q47405816-409F0052-3CAA-460B-95DD-99AFE4880E80 Q48355445-91079196-1D0E-4298-A806-8B809F6CDD95 Q49501136-8383A985-F9DA-4B5B-AF80-B7A2FEB4B5AC Q51013385-95C0BD30-7695-4B58-B3CA-6265DA14FEFE

P2860

Pharmacokinetics of intravitreally injected bevacizumab in vitrectomized eyes.

http://www.wikidata.org/entity/Q37133086

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 04 June 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Pharmacokinetics of intravitreally injected bevacizumab in vitrectomized eyes.

@en

Pharmacokinetics of intravitreally injected bevacizumab in vitrectomized eyes.

@nl

type

label

Pharmacokinetics of intravitreally injected bevacizumab in vitrectomized eyes.

@en

Pharmacokinetics of intravitreally injected bevacizumab in vitrectomized eyes.

@nl

prefLabel

Pharmacokinetics of intravitreally injected bevacizumab in vitrectomized eyes.

@en

Pharmacokinetics of intravitreally injected bevacizumab in vitrectomized eyes.

@nl

P1433

Q37133086-0279229C-0634-4A01-A507-D17A820B8935

P1476

Q37133086-AE98C7D4-94CD-4073-B252-0420BF2B57E2

P2093

Q37133086-095C80E7-CBCA-49CB-8107-C14658B7D448

Q37133086-34B5A7D5-ECDA-4966-934F-04D7B65D4161

Q37133086-BDEA61AA-2C58-4A6A-AD52-9033132EA7C7

Q37133086-C489DC4E-F1AF-4DBD-AEC5-7DFAE24FB5E4

Q37133086-C56BE8CC-B48E-42DE-A852-3505F612D048

P2860

Q37133086-0B26410C-67D7-4E00-9FC4-A270EC490327

Q37133086-0B82836F-B29A-49EA-9596-BAA7A7B65ED2

Q37133086-0BB8A7CE-24E6-49AE-9D44-E1B704B05D22

Q37133086-10BC27EB-E685-4BF5-9BAE-7A1604EF4ED2

Q37133086-2C481BEA-0B6C-4582-BEB4-284F3321300F

Q37133086-4D8690B9-7603-4220-AAF4-D6459584F9D9

Q37133086-548B4F8F-C91D-4250-B942-F47B3EA80184

Q37133086-6256431D-F2B6-4D54-ABD2-82E60323C0F0

Q37133086-69D45547-ECA8-47FA-ADF2-D846DE71D330

Q37133086-7EDF20BC-382A-436D-83B7-7276CE8EB257

P304

Q37133086-42B59E65-E742-472C-95B3-6B798F7238AF

P31

Q37133086-CF5B24ED-2032-4581-BEEF-E981F74DFD5E

P356

Q37133086-5A7B147D-87CE-4FA1-BF72-07C9AB0B93FA

P433

Q37133086-2411D7A4-480B-4631-ABF4-1A1D300B5055

P478

Q37133086-0F8A7B66-1B56-41AF-AFA6-593BE65B6555

P50

Q37133086-BE9B2D76-AE64-44A5-955C-F99F498A9A5B

Q37133086-D4743A29-F9DE-4373-B0AB-4C63D1A93F49

P577

Q37133086-6D8B9165-9361-44D2-A7BB-6BAA92CF9B8B

P5875

Q37133086-E0341F1A-E341-47B0-9675-D3B48CAAC1BB

P698

Q37133086-76F0CBBD-82B2-4DE9-A44F-AC4500D6E357

P921

Q37133086-C02DC31D-A50F-415E-A1A4-819FB9C9AA6E

P932

Q37133086-DB96D5F2-C125-4B09-841E-77B1BDAC08DF

P356

P1433

Journal of Ocular Pharmacology and Therapeutics

P1476

Pharmacokinetics of intravitreally injected bevacizumab in vitrectomized eyes

@en

P2093

Hyuncheol Kim

http://www.w3.org/2001/XMLSchema#string

Ji Hyun Park

http://www.w3.org/2001/XMLSchema#string

Kyu Hyung Park

http://www.w3.org/2001/XMLSchema#string

Se Joon Woo

http://www.w3.org/2001/XMLSchema#string

Sunyoung Park

http://www.w3.org/2001/XMLSchema#string

P2860

Ranibizumab and bevacizumab for neovascular age-related macular degeneration

Ranibizumab for neovascular age-related macular degeneration

Ranibizumab for macular edema following branch retinal vein occlusion: six-month primary end point results of a phase III study.

Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE.

Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders.

Preclinical pharmacokinetics of Ranibizumab (rhuFabV2) after a single intravitreal administration.

Pharmacokinetics of intravitreal bevacizumab (Avastin®) in rabbits

Intravitreal injection of methotrexate in an experimental rabbit model: determination of pharmacokinetics.

Intravitreal therapy for neovascular age-related macular degeneration and inter-individual variations in vitreous pharmacokinetics.

Difference in clearance of intravitreal triamcinolone acetonide between vitrectomized and nonvitrectomized eyes.

P304

612-618

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1089/JOP.2013.0009

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

29

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-06-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

237055366

http://www.w3.org/2001/XMLSchema#string

P698

23735192

http://www.w3.org/2001/XMLSchema#string

P921

P932

3757534

http://www.w3.org/2001/XMLSchema#string